- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/61 - Growth hormone [GH], i.e. somatotropin
Patent holdings for IPC class C07K 14/61
Total number of patents in this class: 319
10-year publication summary
|
31
|
24
|
38
|
29
|
32
|
21
|
23
|
27
|
10
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Opko Biologics Ltd. | 75 |
32 |
| Modernatx, Inc. | 1205 |
10 |
| Novo Nordisk Health Care AG | 357 |
10 |
| Ubiprotein, Corp. | 11 |
8 |
| JCR Pharmaceuticals Co., Ltd. | 219 |
7 |
| Ascendis Pharma Endocrinology Division A/S | 64 |
7 |
| Amunix Pharmaceuticals, Inc. | 75 |
7 |
| Massachusetts Institute of Technology | 9930 |
6 |
| Alteogen Inc. | 61 |
6 |
| Asterion Limited | 23 |
6 |
| Novo Nordisk A/S | 2273 |
6 |
| Lateral IP Pty Ltd | 19 |
6 |
| Molecular Technologies Laboratories LLC | 9 |
6 |
| Novocodex Biopharmaceuticals Co., Ltd. | 11 |
6 |
| Ambrx, Inc. | 192 |
5 |
| The Scripps Research Institute | 1351 |
5 |
| Novo Nordisk Health Care AG | 30 |
5 |
| Pfizer Inc. | 3365 |
4 |
| Duke University | 3015 |
4 |
| Ohio University | 374 |
4 |
| Other owners | 169 |